Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol sodium vs hyaluronic acid for dry eye disease after cataract surgery
jRCT1031210018Recruiting
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in dry eye syndrome (DED) comparing Diquafosol sodium 3% with Hyaluronic acid 0.1% (2 arms). Primary endpoint: Primary: J-OSDI total score at 4 weeks. Started Mar 2025; status: recruiting.
02
Drugs
diquafosolhyaluronic acid
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT1031210018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031210018.